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Purpose. To evaluate capsulotomy shape and posterior capsule opacification (PCO) during an 18-month follow-up for bimanual
femtosecond laser-assisted cataract surgery (FLACS).Methods. 74 eyes operated by a well-trained surgeon with bimanual FLACS
technique using low-energy LDV Z8 (Ziemer Ophthalmic Systems AG, Port, Switzerland) were included in the study.'e follow-
up period was 18± 2 months. Another 91 eyes, which underwent standard bimanual microincision cataract surgery (B-MICS),
served as a control group. In all cases, a BunnyLens AF (Hanita Lenses, Israel) intraocular lens was implanted in the bag. A digital
image of the capsule with slit-lamp retroillumination was performed in all patients at 18 months of follow-up. Image analysis
software (ImageJ) was used to evaluate the shape of the capsulotomy in terms of diameter, area, and circularity. PCO score was
evaluated using EPCO 2000 software. Best corrected visual acuity (BCVA) and endothelial cell count (ECC) were evaluated before
and after surgery at 1 and 18± 2 months. Results. At 18 months, mean capsulotomy diameter was 5.34± 0.21mm while cap-
sulorhexis was 5.87± 0.37mm (p< 0.001) and the deviation area from baseline was 1.13± 1.76mm2 in FLACS and
2.67± 1.69mm2 in B-MICS (p< 0.001). Capsulotomy circularity was 0.94± 0.04 while capsulorhexis was 0.83± 0.07 (p< 0.001).
EPCO score was 0.050± 0.081 in the FLACS group and 0.122± 0.239 in the B-MICS group (p � 0.03). 'e mean BCVA im-
provement was significant in both groups, without a significant difference at 18 months. We noticed a statistically significant
difference in endothelial cell loss at 18 months (FLACS 12.4% and B-MICS 18.1%; p � 0.017). Conclusions. Bimanual FLACS is a
safe and effective technique, as determined in a long-term follow-up. Capsulotomy shape presented higher stability and circularity
in the FLACS group over the 18-month observation period. FLACS resulted in lower PCO scores and endothelial cell loss at 18
months in comparison to B-MICS standard technique.
1. Introduction
Age-related cataract is the second cause of moderate-to-
severe vision impairment among the global population after
uncorrected refractive errors. 'e strong impact of cataract
in the public health justifies ophthalmological community
interest in increasing precision and safety in cataract surgery
[1].
In recent years, the use of a femtosecond laser has been
introduced to assist the surgeon during cataract surgery.
Even though femtosecond laser-assisted cataract surgery
(FLACS) does not seem to show any significant difference
with respect to refractive and visual outcomes when com-
pared to standard phacoemulsification, recent studies
showed better accuracy and reproducibility in the execution
of corneal incisions, highly precise anterior capsulotomies,
and nucleus fragmentation/liquefaction associated with a
lower phacoemulsification energy and limited manipulation
inside the eye [2–5].
'e femtosecond laser LDV Z8 (Ziemer Ophthalmic
Systems AG, Port, Switzerland) is a nonapplanating liquid
patient interface femtolaser system characterized by high
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frequency and low energy [6]. It allows overlapping of very
small laser spots creating a precise cut with minor gas
bubbles and inflammation comparing to other femtolaser
machines. It is entirely mobile, and its small dimensions
allow surgeons to carry out the whole surgical operation in
the same operating room, avoiding questionable patient
transfer.
Bimanual microincision cataract surgery (B-MICS) is a
variant of traditional coaxial phacoemulsification charac-
terized by its incisional microinvasiveness (1.4mm inci-
sions) [7, 8]. 'e increased stability of the anterior chamber,
the separation of the aspiration and the infusion probe
together with the small instrument size, and greater visibility
of the surgical field make it a safe and effective technique to
be used in combination with a femtosecond laser [9–11].
It is well established that a perfect circular and properly
sized capsulotomy is essential for stable results over time and
better intraocular lens (IOL) position, especially for “pre-
mium” cataract surgery (multifocal and toric IOLs) [12].
Moreover, a better IOL overlapping with the anterior cap-
sule has seen to cause less posterior capsule opacification
(PCO) [13].
In a recent study, with a 3-month follow-up period, we
demonstrated that the low-energy/high-frequency proper-
ties of the LDV Z8 laser pulse, combined with the overlapped
pulse-pattern, resulted in highly continuous morphology of
capsule edges. [14]. In addition, a higher apoptosis induction
(Caspase-3 analysis) of the epithelial cells of the capsule edge
has been demonstrated at confocal immunofluorescence in
FLACS in comparison to manually performed capsulorhexis
in standard cataract surgery [14, 15], which could reduce the
incidence of PCO during the follow-up.
To our knowledge, currently there are no studies in-
vestigating PCO incidence and capsulotomy shape in FLACS
with a low-energy/high-frequency femtosecond laser.
'e aim of the study was to evaluate the shape of anterior
capsulotomy and PCO incidence during an 18-month fol-
low-up for bimanual FLACS with a low-energy femtosecond
laser, comparing the results with a control group of standard
B-MICS interventions. Secondary outcomes were best
corrected visual acuity (BCVA) and endothelial cell count
evaluated preoperatively and at 18-month follow-up.
2. Methods
We retrospectively reviewed the data of 165 eyes who un-
derwent cataract surgery at the Institute of Ophthalmology
of the University of Modena and Reggio Emilia between
March 2016 and July 2018. Seventy-four eyes underwent
bimanual cataract surgery using FLACS technique (FLACS);
91 eyes, operated with the B-MICS standard technique, were
chosen as a control group. All surgeries were carried out by
the same expert surgeon (GMC). Patients in both groups
were similar in age, gender, and lens LOCS III score (Ta-
ble 1). 'e study was approved by the Ethics Committee of
the University of Modena and Reggio Emilia (Modena, Italy)
and was conducted in compliance with the Declaration of
Helsinki. Informed consent was obtained before surgery.
Exclusion criteria included eyes with previous surgery,
complicated cataracts (e.g., hard cataracts, traumatic cata-
ract, and pseudoexfoliation syndrome), insufficient mydri-
asis (<4mm), concomitant eye pathologies (e.g., uveitis,
glaucoma, corneal opacities, and diabetic retinopathy), low
endothelial cell count (<1500 cells/mm2), and monocular
patients.
A detailed clinical history evaluation was carried out on
all the patients prior to surgery with best corrected visual
acuity (BCVA) examination, anterior segment biomicro-
scopy, and fundus examination. Biometry was performed
with IOL Master (Carl Zeiss Meditec, Jena, Germany) and
corneal microscopy with a Noncon Robo-CA (Konan
Medical Inc., Hyogo, Japan).
Patients applied nonsteroidal anti-inflammatory drug
(NSAID) drops preoperatively 3 times a day for 3 days before
surgery in both groups.
A consistent mydriasis was obtained before surgery with
the instillation of atropine 1.0%, phenylephrine 10%, and
cyclopentolate 1%, and a locoregional anaesthesia was
carried out with peribulbar block (1.5ml of lidocaine 2% and
1.5ml of bupivacaine 0.5%). All interventions were per-
formed using the same phacoemulsifying machine (Faros,
Oertli Instruments AG, Berneck, Switzerland). Standard
B-MICS and FLACS surgery using the bimanual technique
with the LDV Z8 and IOL implantation through a 1.4mm
incision have been previously described [11].
FLACS capsulotomy diameter was 5.2mm in all cases.
'e surgeon implanted the same model of hydrophilic
acrylic BunnyLensAF IOL (Hanita Lenses, Israel) in all eyes.
BCVA and endothelial cell count (ECC) were evaluated
after surgery at 1 and at 18± 2 months using the instruments
previously described. In particular, ECC was evaluated by
manually counting a group of cells and then providing a
rapid morphometric automated endothelial analysis by the
machine. 'e same experienced doctor carried out all these
examinations.
Digital retroilluminated images of the pseudophakic
anterior segments of the eyes were taken at day-1 and again
at 18± 2 months postoperative follow-up visit using a
camera connected to the slit lamp. Images of the capsule
were taken following dilation of the pupil in all patients.
Image analysis software (ImageJ) was used to evaluate
the shape of the capsulotomy.
ImageJ is biomedical imaging software for scientific
image analysis, which is available as a free download from an
open platform [16, 17].
Capsulotomy/capsulorhexis analysis was carried out in
three phases: firstly, the scale was defined by measuring the
size in pixels for a feature of known true size. In this case, the
6 mm IOL optic plate diameter was first calculated on an
image. 'e number of pixels that corresponded to 6mmwas
calculated. 'en, the contour of the anterior capsule edge
was defined by the operator. Finally, through an automated
analysis, the software calculated the major and minor di-
ameter (mm), the area (mm2), and the coefficient of cir-
cularity (from 0� lower circularity to 1� perfect circularity).
(Figure 1).
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PCO score was evaluated using the computer-based
software Evaluation of Posterior Capsule Opacification 2000
(EPCO2000) at 18± 2 months of follow-up. 'is software is
based on the morphological assessment of PCO and allows a
quantitative and qualitative evaluation of the amount of IOL
surface affected by opacification, as previously described
[18].
'e EPCO2000 software was used to evaluate each image
providing a final PCO score for every eye examined. 'e
PCO score for each eye is calculated by multiplying the
density of the opacification, graded from 0 (none) to 4
(severe), by the fractional PCO area involved behind the
entire IOL optics. Density areas were identified and marked
interactively on the computer screen by the same expert
observer who was blinded to the surgical procedure used
(Figure 2).
'e neodymium-yttrium-aluminum-garnet (Nd : YAG)
laser capsulotomy rate was recorded.
An Excel database (Microsoft Excel 2010 and Microsoft
Office Professional Plus 2010) was used to record all data; for
data analysis, we used Stata 13.1 software (StataCorp LP,
College Station, TX, USA) with Student’s t-test and the
Wilcoxon rank sum test. A post hoc power analysis was
applied to verify the features of two groups. Statistical sig-
nificance was indicated by a p value <0.05.
3. Results
Group A consisted of 74 eyes (40 right eyes and 34 left eyes)
of 42 patients (24 males and 32 females); the average age was
74.83± 5.29 years.
Group B was made up of 91 eyes (52 right eyes and 39 left
eyes) of 63 patients (22 males and 41 females); the average
age was 75.94± 8.95 years.
'e two groups were homogeneous and comparable for
age and gender with no statistical and clinical differences
(Table 1). No intraoperative complications were recorded. A
BunnyLens AF IOL was implanted in all eyes. All IOLs were
implanted in the capsular bag.
Demography of the study population is summarized in
Table 1. Results in both groups are reported in Tables 2–4.
3.1. Continuous Curvilinear Capsulotomy/Capsulorhexis
(CCC). Concerning anterior capsule opening diameters, our
analysis showed that FLACS capsulotomy presented lower
changes in mean diameter and mean area over an 18-month
follow-up than B-MICS capsulorhexis.
In particular, capsulotomy diameter variation was
0.14±0.21mm while that of capsulorhexis was 0.29±0.19mm
(p< 0.001). We registered a lower mean area variation in
FLACS (1.13±1.76mm2) than in B-MICS (2.67±1.69mm2)
(p< 0.001).
Moreover, the circularity index at 18 months was
0.94± 0.04 in FLACS while 0.83± 0.07 in B-MICS
(p< 0.001). All the results are shown in Table 2 and Figure 3.
3.2. PCO Incidence. PCO score in FLACS was lower
(0.050± 0.081) than B-MICS (0.122± 0.239), and the dif-
ference was statistically significant (p � 0.03). PCO was
registered in 5 cases out of 71 (6.8%) for FLACS and 27 cases
out of 91 (29.7%) for B-MICS.
Nd : YAG laser capsulotomy at 18 months was necessary
only in 1 case for FLACS and in 8 cases for B-MICS. Detailed
results are reported in Table 3 and Figure 4.
3.3. Postoperative Results. In the FLACS group, at the 18-
month follow-up mark, a mean BCVA improvement of
0.404± 0.346 LogMAR was observed and was statistically
significant from baseline (p< 0.001). Similarly, in the
B-MICS group, a mean BCVA improvement of 0.400± 0.261
LogMAR was observed (p< 0.001). However, the difference
in the improvement of visual acuity between the two groups
was not statistically significant (p � 0.46).
Regarding the ECC, at the 18-month follow-up visit, a
mean endothelial cell loss of 288± 424 cells/mm2 in Group A
(12.4%) and of 443± 356 cells/mm2 in Group B (18.1%) was
observed and showed a reduction that was statistically
significant between the two groups (p � 0.017) (Table 2).
4. Discussion
With the introduction of femtosecond laser technology,
cataract surgery is experiencing a period of change and
scientific fervor. 'e femtosecond laser does not only assist
and facilitate cataract surgery but also standardizes some
crucial steps: allowing precise and reproducible corneal
microincisions, perfectly circular and centered anterior
capsulotomies, and lens fragmentation, thus, ultimately
leading to a reduction in ultrasound energy.
Recently, we published a paper about the safety and
effectiveness of the combination of FLACS with bimanual
technique [11]. However, the usefulness of FLACS is still
debated since recent meta-analyses showed no statistically
significant differences with standardmanual cataract surgery
in terms of visual and refractive outcomes and general
complications [2–5]. Many surgeons maintain conflicting
views on the effective large-scale spread of this surgical
technique in the near future.
Table 1: Comparison of demographic data at baseline for both groups.
Group A (FLACS) Group B (B-MICS) p value∗
Eyes (n) 74 91 —
Mean age (y) ± SD 73.19± 6.88 74.70± 8.32 p> 0.05
Right/left eyes (n) 40/34 52/39 p> 0.05
Male/female (n) 24/32 (56) 22/41 (63) p> 0.05
Cataract grade (LOCS III) 2.37± 0.49 2.49± 0.50 p> 0.05
Journal of Ophthalmology 3
'e interest of the scientific community is nowadays
rather focused on the evaluation of long-term effects of
FLACS as this procedure could have a positive influence on
IOL stability and PCO incidence over time in comparison to
the standard technique.
A recent study reported a more precise and stable
capsulotomy in FLACS patients in a 12-month follow-up
period using a high-energy/low-frequency femtosecond la-
ser platform in comparison to a control group [19].
In this study, we investigated long-term (18 months)
results obtained by an expert surgeon with bimanual FLACS
technique with a low-energy/high-frequency femtolaser in
terms of capsulotomy shape and PCO incidence. We also
evaluated visual outcomes and endothelial cell loss at 18
months after surgery. We compared results with a control
group. Up to date, there are no studies on a long-term
evaluation of FLACS treated with a low-energy/high-fre-
quency femtosecond laser.
Recent scientific investigations have proven that FLACS
capsulotomies are more predictable, regular, and better-
centered than manual ones, leading to safer surgery and a
positive influence on visual recovery and patient satisfaction
[20]. Moreover, the regularity of the capsulotomy/rhexis
shape and size influences the position of the IOL and the
predictability of the calculated power for the IOL [21, 22]. It
is well known that if the CCC is too small, it can cause a
hyperopic outcome caused by a posteriorly pushed IOL due
to an excessive anterior capsular overlap. If it is too large, the
IOL can be positioned too anteriorly resulting in a myopic
shift. Moreover, if the capsulotomy is not well-centered, the
IOL can be tilted causing astigmatism or a compromised
retinal image [23]. In addition, a capsulotomy, which is
centered on the optical axis of the lens with a diameter of
5.25mm, optimizes prevention of PCO, consistency of ef-
fective lens position (ELP), and capsular strength [12].
In our study, we found that FLACS capsulotomy pre-
sented a significantly higher stability of the capsulotomy
diameter and area at 18 months after surgery. Moreover, the
FLACS group had a significantly higher circularity than
B-MICS capsulorhexis.
Our findings are in line with results reported in the
literature showing significant centration and stability of
FLACS capsulotomy over time in comparison to standard
phacoemulsification. In particular, Pathier et al. [19] eval-
uated the diameter of the rhexis, its centration, and the
position of the IOL in 33 patients who underwent FLACS in
one eye and traditional phacoemulsification in the other;
they found that in the FLACS group, the laser capsulotomies
were more precise, centered, and stable over time.
Similar results were found by Friedman et al., who
showed higher symmetry, centering, and circularity in the
FLACS group compared to the controls [24]. Berk et al. in a
recent study evaluated 995 cases of FLACS and 883 cases of
traditional phacoemulsification after three weeks from
surgery, highlighting more precisely centered, circular, and
reproducible capsulotomies in the first group [25].
High-energy/low-frequency femtolasers were used in the
above mentioned studies. It is known that laser pulse energy
influences the strength of the capsulotomies, which increases
with decreasing the energy [24]. Previous research with the
low-energy/high-frequency Ziemer Z8 showed, similar to
our results, median circularity 0.98 [0.97–0.99] (n� 6) with
FLACS, better accuracy when compared to manual capsu-
lorhexis and importantly very smooth capsulotomy edges
due to low energy [26]. In contrast to ours, the research was
undertaken using human donor eyes and no follow-up
examination was possible.
We also observed a better IOL overlapping with cap-
sulotomy than in manual capsulorhexis. Complete overlap
of the IOL optic by the anterior capsule edge is a well-known
enhancement of the barrier effect to lens epithelial cell
growth. Hollick et al. [27] have long ago reported and
confirmed significantly less PCO with a capsulorhexis
completely covering the edge of the IOL optic.
Posterior capsule opacification (PCO) remains one of the
main long-term complications after cataract surgery, espe-
cially when hydrophilic IOLs are concerned, often seen as
one of the most common causes of nonrefractive decrease in
vision [28, 29]. In our study, PCO score and incidence were
significantly reduced in the FLACS group compared to the
standard phaco group.
In the literature, uncertain data about this controversial
topic are found. Kovacs et al. observed a lower PCO inci-
dence at 18–26 months in the femtolaser group in com-
parison to standard phacoemulsification [13]. On the other
hand, some recent investigations reported results in contrast
with this evidence [25, 30].
Figure 1: Anterior capsule opening analysis with ImageJ software.
(a) Setting of the scale measuring the 6 mm IOL optic plate di-
ameter as known true size. (b) Laying out of the contour of anterior
capsule edge. (c) Software analysis (capsulotomy area indicated in
red).
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PCO reduction could be attributed to a well-centered
capsulotomy or to the lens epithelial cell apoptosis at the
margin of the capsulotomy as previously described [14].
With regards to cell apoptosis and loss, different reports
exist, but all are in agreement that the low-energy minimizes
cell loss and reduces peripheral damage along the capsu-
lotomy [31–33]. 'us, the cell loss at the capsulotomy
margin alone cannot explain the lower occurrence of the
PCO in low-energy FLACS.
It is well demonstrated that FLACS procedures performed
with high-energy lasers are associatedwith higher prostaglandin
and cytokine concentrations and higher rates of anterior capsule
damage [34], whereas reduced inflammation could also de-
crease the risk of PCO induction, and Liu et al. found only low
amounts of interleukin (IL)-1α and−1β in the anterior chamber
aqueous humour of patients who underwent FLACS with the
low-energy Z8 [35]. 'e IL-1α of 0.5±0.2 pg/ml was only
slightly higher compared tomanual surgery (0.05±0.05pg/ml),
and the IL-1β showed almost similar values for the FLACS and
manual surgery: 0.5±0.3 pg/ml and 0.5±0.4 pg/ml respectively.
'e numbers reportedwith high-energy lasers are up to 25.6 pg/
ml [36].
Interleukin-1 receptor antagonist has been shown to sup-
press the proliferation of lens epithelial cells [37], and this might
provide an explanation to our findings and support a favorable
view of low-energy FLACS in the aspect of the occurrence of
postoperative PCO [38]. For these reasons, we suppose that a
low-energy femtosecond laser could give even more advantages
in terms of a reduction of PCO occurrence in FLACS.
Regarding postoperative results, we registered a significant
improvement in mean BCVA in both groups, as previously
found for FLACS [2–5, 39], without any significant difference
between the two groups. As for endothelial cell loss, the results
obtained in our study showed a reduced loss in the FLACS
group than in the control group, and this difference was sta-
tistically significant. 'is is likely due to the reduction in phaco
energy, which has been shown to harm the endothelium. 'e
positive impact of FLACS on the endothelium has been widely
reported in the literature regardless of the femtolaser system
used [11, 40–45] even though recently a few papers reported on
no significant differences in endothelial cell loss between the two
techniques [46, 47]. 'e present study reports on a longer
follow-up period, and the results are obtained from a low-
energy femtosecond laser, which is a first report according to
our knowledge.
A limitation of our study was its retrospective nature:
a randomized prospective clinical trial and another blind























Figure 2: PCO analysis with EPCO2000 software in two study cases: (a) FLACS, patients (n), 41; (b) B-MICS, patients (n), 52. Note. Left
pictures are from the slit lamp (native image), and right pictures are those from the correspondent software analysis (evaluated image).
Evaluation results and legend for each single image are on the left.
Table 2: CCC diameter and area, BCVA, and ECD results at baseline and 18 months for the two groups.
FLACS B-MICS
Baseline 18 months Difference Baseline 18 months Difference
CCC diameter (mm) 5.20 5.34± 0.21 0.14 ± 0.21 5.60± 0.40 5.87± 0.37 0.29 ± 0.19
CCC area (mm2) 21.24 22.37± 1.69 1.13 ± 1.76 24.93± 3.50 27.16± 3.75 2.67 ± 1.69
BCVA (logMar) 0.420± 0.342 0.016± 0.065 0.404 ± 0.346 0.443± 0.238 0.043± 0.020 0.400 ± 0.261
Endothelial cell density (cells/mm2) 2290± 466 2007± 230 288 ± 424 2448± 337 2005± 489 443 ± 356
Table 3: PCO score and percentage of PCO cases and YAG laser in
the two groups.
FLACS (74) B-MICS (91)
PCO score 0.050± 0.081 0.122± 0.239
Total cases with PCO 6.8% (5 cases) 29.7% (27 cases)
Nd : YAG laser 1.4% (1 cases) 8.8% (8 cases)
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preferred. Another limitation was that data collection at
18-month follow-up was not at that precise time-point
for every patient but varied ±2 months. Moreover, en-
dothelial cell loss was not assessed by a blind observer.
In conclusion, low-energy femtosecond laser tech-
nology in conjunction with the advantages of B-MICS
technique shows good results in cataract surgery in a
long-term follow-up. FLACS with LDV Z8 showed a
more stable capsulotomy shape and a higher circularity,
when compared to standard capsulorhexis, and registered
a significantly decreased PCO score with a lower YAG
laser incidence than in the standard phacoemulsification
group. 'ese findings have a significant impact on cat-
aract surgery as stable capsulotomy influences the IOL
centration. Furthermore, a low incidence of PCO reduces
the need for a YAG-laser procedure, which is expensive
and has related risks such as retinal tear or detachment.
Moreover, a reduced endothelial cell loss in FLACS was
also retrospectively confirmed in our 18-month follow-up
study.
Further studies will be needed to confirm the data, in
particular the analysis of visual outcomes after toric, mul-
tifocal, or trifocal IOL implantation or in complicated cases




























Figure 3: Box plot with whiskers indicating 95% confidence intervals for diameter (a) and area (b) variation in an 18-month follow-up
period. DM� diameter.
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conditions in which overall reduced energy and mechanical
manipulation should be needed Table 4.
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